Ontex Group N.V.
Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Semi-annual Revenue
•
in mil. unless spec.Semi-annual Earnings Per Share
•
in mil. unless spec.Semi-annual Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Ontex Group NV, a leading international developer and producer of personal hygiene products, manufactures high-quality baby care items including diapers and pants under retailer brands such as Cremer, Canbebe, Helen Harper, Moltex, Ontex Dreamshields, Pom Pom and Sapeka; feminine care products comprising sanitary towels, panty liners and tampons under brands including NAT and Silhouette; and adult care solutions such as pants, diapers, incontinence towels and bed protection under brands like Adultmax Maturidade, Bigfral, iD, Canped, Lille Healthcare, Kylie, Serenity, Orizon and Moviment. The company serves retailers, institutional and private healthcare providers, and consumers through its innovative offerings distributed in over 100 countries, with manufacturing and operations focused on core markets in Europe and North America. Founded in 1979 and headquartered in Aalst, Belgium, Ontex operates as a subsidiary of Groupe Bruxelles Lambert SA and maintains production facilities, R&D centers and sales offices across these regions. Ontex continues its strategic transformation to enhance competitiveness, including the divestment of non-core emerging market operations: it sold its Mexican business to Softys in 2023, entered a binding agreement in September 2024 to sell its Brazilian activities to Softys for approximately €110 million enterprise value (expected to close in the first half of 2025), and completed the sale of its Turkish business to Dilek Grup in November 2025 for net proceeds of about €25 million. These transactions refocus the portfolio on retail brands and healthcare in Europe and North America, reduce indebtedness and support growth initiatives such as €45 million in 2025 capital expenditures, with nearly half allocated to North American expansion including new contract production starting in Q3 2025. Additionally, Ontex announced in June 2024 plans to restructure Belgian operations by exiting the Eeklo site, transforming Buggenhout into a center of excellence for medium and heavy incontinence products with a €40 million investment, and optimizing distribution for cost efficiency.
Company News
Ontex Group NV (ONXYY) Q2 2026 Earnings Call Transcript
Ontex Group NV (ONXYY) Q1 2026 Earnings Call Transcript
Ontex Group NV (ONXYY) Q4 2025 Earnings Call Transcript
Ontex Group NV (ONXYY) Q3 2025 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2025 Earnings Call Transcript
Ontex Group NV announces the redemption of the outstanding 3.500% senior notes due 2026
Ontex Group NV (ONXXF) Q1 2025 Earnings Call Transcript
Ontex Group NV announces the results of its cash tender offer for its outstanding €580,000,000 3.500% senior notes due 2026
Ontex Group NV announces pricing of €400 million senior notes
Ontex Group NV announces offering of €400 million senior notes
Ontex Group NV announces the launch of a cash tender offer for up to €400,000,000 aggregate principal amount of its outstanding €580,000,000 3.500% senior notes due 2026
Ontex Group NV (ONXXF) Q4 2024 Earnings Call Transcript
Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup
Ontex Group NV (ONXXF) Q3 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q1 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q4 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q3 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q1 2023 Earnings Call Transcript